Modus Therapeutics Holding AB
556851-9523ActiveSwedish biotech developing sevuparin for severe inflammatory conditions.
Overview
- 1–4
- Employees
- 500–749K SEK
- Revenue
- 2011
- Founded
Key Decision Makers
John Öhd
Chief Executive Officer
Johan Dighed
Board member
Viktor Drvota
Chairman
Michael Forer
Member of the Nomination Committee
+3 more contacts in Funnelfeedr
Description
Modus Therapeutics is a Swedish biotechnology company focused on developing novel treatments for severe medical conditions. Their primary focus is the development of their proprietary polysaccharide, sevuparin. Sevuparin is being investigated as a potential therapeutic agent for several high unmet m...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Konsultverksamhet avseende företags organisation
- Legal Form
- Aktiebolag
- VAT Number
- SE556851952301
Decision Makers
7 contacts in FunnelfeedrJohn Öhd
Chief Executive Officer
Johan Dighed
Board member
Viktor Drvota
Chairman
Michael Forer
Member of the Nomination Committee
Ellen Donnelly
Board Member
Claes Lindblad
CFO & Head of IR
Ellen K. Donnelly
Board Member
Similar Companies
20 similar companies in FunnelfeedrSangair AB
3 employeesDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Aptahem AB
0 employeesBiotech company developing RNA therapeutics for acute inflammatory diseases like sepsis.
Kyowa Kirin International NewCo Sweden AB
Global specialty pharmaceutical company focused on innovative drug development.
ZEALAND PHARMA A/S
0 employeesDeveloping peptide medicines for metabolic health challenges globally.
Disruptive Pharma AB (publ)
5–9 employeesSwedish biotech developing novel kidney disease therapies based on proprietary peptides.
Browse More
Modus Therapeutics Holding AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo